Diabetes Drug Recall Expands due to Excess Levels of Cancer-Causing Agent

Over the past several months, a number of Metformin recalls have caused concern and near-panic in the healthcare community and among consumers.  Various batches of Metformin have been recalled due to containing higher-than-acceptable levels of the carcinogen N-Nitrosodimethylamine (NDMA).  Now, the already significant diabetes drug recall has expanded once again....